Balloon-Occluded Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma
Indian Journal of Radiology and Imaging · 01.07.2026 · 36 (03) · 405-411
DOI: 10.1055/s-0046-1822652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Radiology and Imaging, erschienen am 01.07.2026. Verfasst von Amar Mukund und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Institute of Liver and Biliary Sciences (ILBS), New Delhi, India. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Transarterial chemoembolization (TACE) is considered standard therapy for intermediate-stage hepatocellular carcinoma (HCC). However, conventional TACE (cTACE) and drug-eluting bead TACE (DEB-TACE) are limited by high recurrence rates. Recent studies have shown that balloon-occluded TACE (B-TACE) allows enhanced intratumoral drug deposition and may improve outcomes. This study aimed to evaluate the short-term outcome of B-TACE for HCC. Materials and Methods This retrospective single-center study was conducted after obtaining approval from the institutional review board. Fifty patients with unresectable HCC were treated with B-TACE between October 2023 and September 2024. Tumor response was assessed using LI-RADS Treatment Response (LR-TR) and mRECIST (Modified Response Evaluation Criteria in Solid Tumors). Progression-free survival (PFS) was analyzed with Kaplan–Meier methods, and predictors of response were evaluated by logistic regression. Lipiodol deposition was classified into three types as a surrogate marker of drug distribution.
Results
The overall response rate was 72.0%, with a complete response in 54.0% of patients. Subgroup analysis revealed that patients with Barcelona Clinic Liver Cancer (BCLC) stage A and B achieved a higher overall response rate of 77.3% (34/44), compared with 33.3% (2/6) in patients with BCLC stage C. At 1 year, 68.0% remained progression-free, with significantly higher PFS in those achieving early complete response/partial response compared with stable disease/progressive disease (83.3 vs. 28.6%, p < 0.001). Type I lipiodol deposition strongly correlated with complete response (93.8 vs. 37.5% for type II and 0% for type III; p < 0.001) and superior PFS. Multivariable analysis identified lipiodol deposition pattern, number of lesions, and baseline AFP as independent predictors of response. Complications were manageable (30.0%, mainly fever and transaminitis), with no treatment-related mortality.
Conclusion
B-TACE demonstrated high efficacy and acceptable safety in HCC, with lipiodol deposition serving as a key predictor of outcome. These findings support B-TACE as a promising alternative to cTACE/DEB-TACE, particularly in intermediate-stage disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Interventional Radiology, Institute of Liver and Biliary Sciences (ILBS), New Delhi, India.
- Department of Hepatology, Institute of Liver and Biliary Sciences (ILBS), New Delhi, India.
ORCID-Profile: Amar Mukund, Kaustav Jain, Yashwant Patidar
Zitieren
APA
Mukund, A., Jain, K., Sharma, L. K., Tyagi, V., Patidar, Y., Shasthry, S. M., Choudhary, A. K., & Sarin, S. K. (2026). Balloon-Occluded Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. Indian Journal of Radiology and Imaging, 36(03), 405-411. https://doi.org/10.1055/s-0046-1822652
Vancouver
Mukund A, Jain K, Sharma LK, Tyagi V, Patidar Y, Shasthry SM, et al. Balloon-Occluded Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. Indian Journal of Radiology and Imaging. 2026;36(03):405-411. doi:10.1055/s-0046-1822652
BibTeX
@article{Mukund2026,
author = {Mukund, Amar and Jain, Kaustav and Sharma, Lokesh K and Tyagi, Vasav and Patidar, Yashwant and Shasthry, Saggere M and Choudhary, Ashok K and Sarin, Shiv K},
title = {Balloon-Occluded Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma},
journal = {Indian Journal of Radiology and Imaging},
year = {2026},
volume = {36},
number = {03},
pages = {405--411},
doi = {10.1055/s-0046-1822652}
}
EUVIMED